Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.0B | 8.3B | 8.0B | 8.5B |
Cost of revenue | 5.2B | 5.4B | 5.3B | 5.5B |
Gross profit | 2.8B | 3.0B | 2.7B | 3.0B |
Operating expense | ||||
Research & development | 96M | 100M | 98M | 108M |
Selling general and admin | 1.9B | 1.9B | 1.7B | 1.8B |
Other operating expenses | -31M | -45M | -89M | -6M |
Operating income | 927M | 1.1B | 1.0B | 1.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 808M | 943M | 872M | 947M |
Tax provision | 185M | 211M | 172M | 217M |
Net income | 623M | 732M | 700M | 730M |
Basic EPS | 1.7 | 2.0 | 1.9 | 2 |
Diluted EPS | 1.7 | 2.0 | 1.9 | 2 |
Basic average shares | 364.3M | 364.7M | 364.6M | 364.5M |
Diluted average shares | 364.4M | 364.7M | 364.6M | 364.5M |
EBITDA | 927M | 1.1B | 1.0B | 1.1B |
Net income from continuing op. | 927M | 1.1B | 1.0B | 1.1B |
Minority interests | 0 | 1M | 0 | -1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |